GSDMD and non-small cell lung carcinoma: It is shown the higher expression of GSDMD, which is the classical executioner of pyroptosis, is associated with larger tumor sizes and more advanced tumor-node-metastasis stage in non-small cell lung cancer (NSCLC) patients.